TSS
ENZ

Two Sigma Securities’s Enzo Biochem, Inc. ENZ Stock Holding History

Two Sigma Securities’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,746
Closed -$7.31K – 2243
2025
Q1 		$7.31K Buy
+19,746
New +$10.9K ﹤0.01% 1268
2017
Q3 		– Sell
-10,830
Closed -$120K – 1271
2017
Q2 		$120K Buy
+10,830
New +$101K 0.02% 634

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Two Sigma Securities's ENZ Position: Q2 2025 in Review

Two Sigma Securities sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 19,746 shares — an estimated $7.31K sold.

Two Sigma Securities first reported a position in ENZ in Q2 2017 and held it in 2 quarters. The position peaked at $120K in Q2 2017. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Two Sigma Securities reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 19,746 Enzo Biochem, Inc. shares in Q2 2025, an estimated $7.31K.
  • Two Sigma Securities first reported a position in Enzo Biochem, Inc. in Q2 2017 and held it in 2 quarters.
  • Two Sigma Securities's Enzo Biochem, Inc. position peaked at $120K in Q2 2017.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.